Details

NameSymbolSector
NATCO PHARMA LIMITEDNATCOPHARMPharmaceuticals
Open
813.7
High
825.1
Low
808
Close
822.55
Volume
331044
Exchange
nse
Time
03-Oct-2025

Outlook

Score:  

4.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Natco Pharma is  
None
Estimated Stoploss of Natco Pharma is ₹  
808
Natco Pharma has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Natco Pharma is  
Unpredictableℹ
. 

Trend

Natco Pharma is in  
Sideways trendℹ
. 
Price of Natco Pharma is  
Downℹ
 by  

5.46

%. 
Target
Buy @ 

772.79

Sell @ 

1036.13

Current @ 

822.55

Volume

The trade volumes of Natco Pharma have become  
Deficientℹ
The volume trend for Natco Pharma is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Natco Pharma is  

Down

 by  

54.95

% 

Valuation

The current market price of Natco Pharma is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 8630cr and total assets worth ₹ 8630cr, the balance sheet of Natco Pharma is:  
Balancedℹ
. 
Cashflow
Natco Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 49cr

. It is  
Upℹ
 by  

180.33

%. 

(*Mar 2025)

50.75% i.e. ₹ 1696cr earned in operatingℹ
42.31% i.e. ₹ 1414cr spent in investingℹ
6.28% i.e. ₹ 210cr spent in financingℹ
0.66% i.e. ₹ 22cr spent in otherℹ
Natco Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 61cr

. It is  
Downℹ
 by  

405

%. 

(*Mar 2024)

48.54% i.e. ₹ 1211cr earned in operatingℹ
41.36% i.e. ₹ 1032cr spent in investingℹ
9.86% i.e. ₹ 246cr spent in financingℹ
0.24% i.e. ₹ 6cr earned in otherℹ
Income
The income of Natco Pharma is  

₹ 1390cr

 and  

Profit

 is :  

₹ 480cr

(*Jun 2025)

Natco Pharma Profit is up by:  

18.23

% and Income is Up by:  

8

% 

(*Jun 2025)

The income of Natco Pharma is  

₹ 1287cr

 and  

Profit

 is :  

₹ 406cr

(*Mar 2025)

Natco Pharma Profit is up by:  

207.58

% and Income is Up by:  

97.7

% 

(*Mar 2025)

The income of Natco Pharma is  

₹ 651cr

 and  

Profit

 is :  

₹ 132cr

(*Dec 2024)

Natco Pharma Profit is down by:  

80.47

% and Income is Down by:  

54.6

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.